# TEVA PHARMACEUTICAL INDUSTRIES LTD > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:1ab4e417-6727-4cb7-8135-8765fcabc050 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 53 | | Claims under review | 2 | | Evidence records | 13 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-24T04:45:10.88591+00:00 | | Last reviewed | 2026-10-24T04:45:10.88591+00:00 | ## Identity - Legal name: TEVA PHARMACEUTICAL INDUSTRIES LTD - Display name: TEVA PHARMACEUTICAL INDUSTRIES LTD ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-24T23:40:06.115725+00:00 | | Completeness | 0.409 | | Record Quality | 0.807 | | Directors | 10 | | Committees | 13 | | Governance events | 25 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Amir Elstein: Director. Status: current. Independent: true. Since: 2009-01-01. Committees: Audit (member); Corporate Governance and Nominating (member); Corporate Governance and Nominating; Audit; Finance and Investment (member); Finance and Investment (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9 - Chen Lichtenstein: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compliance; Finance and Investment (member); Compliance (member); Finance and Investment (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10 - Gerald Lieberman: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (chair); Audit · Chair; Human Resources and Compensation; Finance and Investment (member); Finance and Investment (member); Human Resources and Compensation (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11 - Perry D. Nisen: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Compliance (member); Human Resources and Compensation (member); Science and Technology (member); Science and Technology; Compliance; Human Resources and Compensation (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12 - Prof. Ronit Satchi-Fainaro: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compliance (member); Compliance; Science and Technology; Corporate Governance and Nominating (member); Corporate Governance and Nominating (member); Science and Technology (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13 - Richard Francis: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14 - Roberto Mignone: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (member); Corporate Governance and Nominating (chair); Corporate Governance and Nominating · Chair; Finance and Investment; Audit (member); Finance and Investment (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15 - Rosemary A. Crane: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Human Resources and Compensation (chair); Human Resources and Compensation · Chair; Science and Technology (member); Science and Technology (member). claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16 - Sol J. Barer: Chairman of the Board. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8 - Tal Zaks: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17 ## Committees - Audit (audit). Chair: Gerald Lieberman. Members: Gerald Lieberman (chair, current); Amir Elstein (member, current); Chen Lichtenstein (member, current); Roberto Mignone (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:audit - Audit · Chair; Human Resources and Compensation; Finance and Investment (audit). Chair: NOT_PUBLISHED. Members: Gerald Lieberman (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:audit-chair-human-resources-and-compensation-finance-and-investment - Audit; Compliance; Finance and Investment (audit). Chair: NOT_PUBLISHED. Members: Chen Lichtenstein (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:audit-compliance-finance-and-investment - Compliance (other). Chair: NOT_PUBLISHED. Members: Chen Lichtenstein (member, current); Perry D. Nisen (member, current); Prof. Ronit Satchi-Fainaro (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:compliance - Compliance; Science and Technology; Corporate Governance and Nominating (nominating_governance). Chair: NOT_PUBLISHED. Members: Prof. Ronit Satchi-Fainaro (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:compliance-science-and-technology-corporate-governance-and-nominating - Corporate Governance and Nominating (nominating_governance). Chair: Roberto Mignone. Members: Roberto Mignone (chair, current); Amir Elstein (member, current); Prof. Ronit Satchi-Fainaro (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating - Corporate Governance and Nominating · Chair; Finance and Investment; Audit (audit). Chair: NOT_PUBLISHED. Members: Roberto Mignone (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-chair-finance-and-investment-audit - Corporate Governance and Nominating; Audit; Finance and Investment (audit). Chair: NOT_PUBLISHED. Members: Amir Elstein (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:corporate-governance-and-nominating-audit-finance-and-investment - Finance and Investment (finance). Chair: NOT_PUBLISHED. Members: Amir Elstein (member, current); Chen Lichtenstein (member, current); Gerald Lieberman (member, current); Roberto Mignone (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:finance-and-investment - Human Resources and Compensation (compensation). Chair: Rosemary A. Crane. Members: Rosemary A. Crane (chair, current); Gerald Lieberman (member, current); Perry D. Nisen (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation - Human Resources and Compensation · Chair; Science and Technology (compensation). Chair: NOT_PUBLISHED. Members: Rosemary A. Crane (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:human-resources-and-compensation-chair-science-and-technology - Science and Technology (technology). Chair: NOT_PUBLISHED. Members: Perry D. Nisen (member, current); Prof. Ronit Satchi-Fainaro (member, current); Rosemary A. Crane (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology - Science and Technology; Compliance; Human Resources and Compensation (compensation). Chair: NOT_PUBLISHED. Members: Perry D. Nisen (member, current). committee_id=alpha:committee:teva-pharmaceutical-industries-ltd:science-and-technology-compliance-human-resources-and-compensation ## Executive leadership - Amir Weiss: Senior VP & Chief Accounting Officer [CAO]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18 - Christopher J. Stevo: Senior Vice President of Investor Relations & Competitive Intelligence. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19 - David R. Mcavoy: Executive VP & Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20 - Eliyahu Sharon Kalif: Executive VP & CFO [CFO]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21 - Eric A. Hughes: Executive Vice President of Global R&D and Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22 - Kathleen Veit: Senior Vice President, Global Compliance & Ethics Officer. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23 - Matthew Shields: Executive Vice President of Global Operations. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24 - Richard Francis: President, Chief Executive Officer & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25 - Richard Gordon Daniell: Executive Vice President of European Commercial. Status: unknown. claim_id=alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26 ## Governance events - DIRECTOR_APPOINTED: Chen Lichtenstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1qkxtil12pt8n5 - COMMITTEE_CREATED: Audit; Compliance; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1yh4sqr1ttoctp - COMMITTEE_MEMBER_ADDED: Chen Lichtenstein member of Audit; Compliance; Finance and Investment, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1wcs26tl5612v - DIRECTOR_APPOINTED: Richard Francis seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:16il4pua3nihm - DIRECTOR_APPOINTED: Tal Zaks seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1qjua7njwulnn - DIRECTOR_APPOINTED: Prof. Ronit Satchi-Fainaro seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1pmydy3154cqy1 - COMMITTEE_CREATED: Compliance; Science and Technology; Corporate Governance and Nominating committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:amafiv18a3vuh - COMMITTEE_MEMBER_ADDED: Prof. Ronit Satchi-Fainaro member of Compliance; Science and Technology; Corporate Governance and Nominating, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:gkw9k01d66ric - DIRECTOR_APPOINTED: Perry D. Nisen seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1mrevx1wuiunr - DIRECTOR_APPOINTED: Roberto Mignone seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:115afeo15dpnok - COMMITTEE_CREATED: Corporate Governance and Nominating · Chair; Finance and Investment; Audit committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:11znebih1wwnc - COMMITTEE_MEMBER_ADDED: Roberto Mignone member of Corporate Governance and Nominating · Chair; Finance and Investment; Audit, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1i25mb6g79rtu - COMMITTEE_CREATED: Science and Technology; Compliance; Human Resources and Compensation committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1wchka51xrdkqv - COMMITTEE_MEMBER_ADDED: Perry D. Nisen member of Science and Technology; Compliance; Human Resources and Compensation, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:128sitl13fd4jj - DIRECTOR_APPOINTED: Gerald Lieberman seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1ovsdeg1ie5ymm - DIRECTOR_APPOINTED: Rosemary A. Crane seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:szo76d14d78it - DIRECTOR_APPOINTED: Sol J. Barer seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:asbc54r2q4wu - BOARD_CHAIR_CHANGED: Sol J. Barer chairs board TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1ue1iyg3h291q - COMMITTEE_CREATED: Audit · Chair; Human Resources and Compensation; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:ib1mkg6zr5xi - COMMITTEE_MEMBER_ADDED: Gerald Lieberman member of Audit · Chair; Human Resources and Compensation; Finance and Investment, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:qthtw71fbayw9 - COMMITTEE_CREATED: Human Resources and Compensation · Chair; Science and Technology committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:u1q349muv71x - COMMITTEE_MEMBER_ADDED: Rosemary A. Crane member of Human Resources and Compensation · Chair; Science and Technology, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:4ealy1szuse9 - DIRECTOR_APPOINTED: Amir Elstein seat on TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1luawxm36983q - COMMITTEE_CREATED: Corporate Governance and Nominating; Audit; Finance and Investment committee of TEVA PHARMACEUTICAL INDUSTRIES LTD, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:asgttw1ggs4a2 - COMMITTEE_MEMBER_ADDED: Amir Elstein member of Corporate Governance and Nominating; Audit; Finance and Investment, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-24T04:45:10.88591+00:00. event_id=alpha:event:transition:1hymqu81ctsfl0 ## Scoped resources - `alpha://company/teva-pharmaceutical-industries-ltd` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record - `alpha://company/teva-pharmaceutical-industries-ltd/identity` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=identity - `alpha://company/teva-pharmaceutical-industries-ltd/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=corporate-structure - `alpha://company/teva-pharmaceutical-industries-ltd/board` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=board - `alpha://company/teva-pharmaceutical-industries-ltd/committees` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=committees - `alpha://company/teva-pharmaceutical-industries-ltd/leadership` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=leadership - `alpha://company/teva-pharmaceutical-industries-ltd/ownership` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=ownership - `alpha://company/teva-pharmaceutical-industries-ltd/financials` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=financials - `alpha://company/teva-pharmaceutical-industries-ltd/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=capital-structure - `alpha://company/teva-pharmaceutical-industries-ltd/compensation` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=compensation - `alpha://company/teva-pharmaceutical-industries-ltd/governance` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=governance - `alpha://company/teva-pharmaceutical-industries-ltd/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=shareholder-governance - `alpha://company/teva-pharmaceutical-industries-ltd/audit` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=audit - `alpha://company/teva-pharmaceutical-industries-ltd/legal` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=legal - `alpha://company/teva-pharmaceutical-industries-ltd/risk` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=risk - `alpha://company/teva-pharmaceutical-industries-ltd/cyber` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=cyber - `alpha://company/teva-pharmaceutical-industries-ltd/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=ai-governance - `alpha://company/teva-pharmaceutical-industries-ltd/agents` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=agents - `alpha://company/teva-pharmaceutical-industries-ltd/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=ecosystem - `alpha://company/teva-pharmaceutical-industries-ltd/events` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=events - `alpha://company/teva-pharmaceutical-industries-ltd/relationships` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=relationships - `alpha://company/teva-pharmaceutical-industries-ltd/assessments` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=assessments - `alpha://company/teva-pharmaceutical-industries-ltd/evidence` (contract): https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Compliance","category":"other","role":"member","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:37: `{"kind":"committee_appointment","original_name":"Corporate Governance and Nominating","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Corporate Governance and Nominating","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:39: `{"kind":"committee_appointment","original_name":"Corporate Governance and Nominating","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:amir-elstein","name":"Amir Elstein"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:42: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:chen-lichtenstein","name":"Chen Lichtenstein"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:43: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:44: `{"kind":"committee_appointment","original_name":"Finance and Investment","category":"other","role":"member","person":{"alpha_id":"alpha:person:roberto-mignone","name":"Roberto Mignone"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:46: `{"kind":"committee_appointment","original_name":"Human Resources and Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:rosemary-a-crane","name":"Rosemary A. Crane"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:47: `{"kind":"committee_appointment","original_name":"Human Resources and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:gerald-lieberman","name":"Gerald Lieberman"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:48: `{"kind":"committee_appointment","original_name":"Human Resources and Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:50: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:perry-d-nisen","name":"Perry D. Nisen"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:51: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:prof-ronit-satchi-fainaro-tevjf","name":"Prof. Ronit Satchi-Fainaro"},"source_id":"board_seats"}` - Claim alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:52: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:rosemary-a-crane","name":"Rosemary A. Crane"},"source_id":"board_seats"}` ## Leadership - Sol J. Barer: Chairman of the Board. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:8. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069. - Amir Elstein: Director, Corporate Governance and Nominating; Audit; Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:9. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Chen Lichtenstein: Director, Audit; Compliance; Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Gerald Lieberman: Director, Audit · Chair; Human Resources and Compensation; Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:11. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Perry D. Nisen: Director, Science and Technology; Compliance; Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:12. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Prof. Ronit Satchi-Fainaro: Director, Compliance; Science and Technology; Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:13. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069. - Richard Francis: Director. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:14. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Roberto Mignone: Director, Corporate Governance and Nominating · Chair; Finance and Investment; Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:15. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Rosemary A. Crane: Director, Human Resources and Compensation · Chair; Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:16. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Tal Zaks: Director. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:17. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3. - Amir Weiss: Senior VP & Chief Accounting Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834. - Christopher J. Stevo: Senior Vice President of Investor Relations & Competitive Intelligence. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa. - David R. Mcavoy: Executive VP & Chief Legal Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2. - Eliyahu Sharon Kalif: Executive VP & CFO. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b. - Eric A. Hughes: Executive Vice President of Global R&D and Chief Medical Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1. - Kathleen Veit: Senior Vice President, Global Compliance & Ethics Officer. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110. - Matthew Shields: Executive Vice President of Global Operations. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8. - Richard Francis: President, Chief Executive Officer & Director. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0. - Richard Gordon Daniell: Executive Vice President of European Commercial. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Gerald Lieberman; Members Gerald Lieberman (Chair); Amir Elstein; Chen Lichtenstein; Roberto Mignone. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Compliance: Chair not stated; Members Chen Lichtenstein; Perry D. Nisen; Prof. Ronit Satchi-Fainaro. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Corporate Governance and Nominating: Chair Roberto Mignone; Members Roberto Mignone (Chair); Amir Elstein; Prof. Ronit Satchi-Fainaro. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Finance and Investment: Chair not stated; Members Amir Elstein; Chen Lichtenstein; Gerald Lieberman; Roberto Mignone. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Human Resources and Compensation: Chair Rosemary A. Crane; Members Rosemary A. Crane (Chair); Gerald Lieberman; Perry D. Nisen. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:45. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Science and Technology: Chair not stated; Members Perry D. Nisen; Prof. Ronit Satchi-Fainaro; Rosemary A. Crane. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_record:49. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - TEVA PHARMACEUTICAL INDUSTRIES LTD. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. ## Entity Status - Public listing published. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. ## Published Fact - US. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. - IL. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. - Healthcare. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. ## Committee Appointment - Gerald Lieberman: chair, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Amir Elstein: member, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Chen Lichtenstein: member, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Roberto Mignone: member, Audit. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Chen Lichtenstein: member, Compliance. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Perry D. Nisen: member, Compliance. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Prof. Ronit Satchi-Fainaro: member, Compliance. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Roberto Mignone: chair, Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Amir Elstein: member, Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Prof. Ronit Satchi-Fainaro: member, Corporate Governance and Nominating. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Amir Elstein: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Chen Lichtenstein: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Gerald Lieberman: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:43. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Roberto Mignone: member, Finance and Investment. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Rosemary A. Crane: chair, Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:46. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Gerald Lieberman: member, Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:47. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Perry D. Nisen: member, Human Resources and Compensation. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:48. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Perry D. Nisen: member, Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:50. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Prof. Ronit Satchi-Fainaro: member, Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:51. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. - Rosemary A. Crane: member, Science and Technology. Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:committee_appointment:52. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60. ## Security Listing - TEVA (NYSE). Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:security_listing:53. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. - TEVA (TASE). Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:security_listing:54. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. - TEVJF (OTC). Claim: alpha:claim:company:1ab4e417-6727-4cb7-8135-8765fcabc050:security_listing:55. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:df3c9515a53fb38c94805249ae03057809abbcf6caf890ee3d91afecdd34f723: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd). - alpha:projection-evidence:document:17461fa3d5493d3b30182a87e5400dc5c54917c430dd17c64ebd57ff63626069: [DEF 14A d11454ddef14a.htm](https://www.sec.gov/Archives/edgar/data/818686/000119312524097745/d11454ddef14a.htm). - alpha:projection-evidence:document:37fef82ead73a2c8ab044255b17614c06e3d7a87bb628b1ddcdac2c7d5735bf3: [DEF 14A d11977ddef14a.htm](https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm). - alpha:projection-evidence:document:b35f77c27991bb5d53fb217d5341760f27e8ef78affed273ecede8c8ad564834: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:3127308aa3cb1944dab9fc50df63e4750f721ac8840ba756fd276d7455831faa: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:bedb35712599178b10aaea6d30b7f48140f30ad5a489d8713f6a88171b29f5e2: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:6db10fc291abc3f16e22c4ed40ca600b9de6cc382722b58fa8aa8792d0ee3a4b: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:2cfd57eb48fbc6e6cdb965ef825ffb62cb6e774aaa649b7c81c75212c2c163a1: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:31e2475c90141d450c3ea7e98f59c770cc5891862868c22b4b4d49f78153f110: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:2cd73c5146f224c38031862cb66c63314661926134e851ee01c2070e1334c9f8: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:25b799e360910f8efe7c2a8d628d7396d74d0f78b80711428ba596e7f078a8e0: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:document:f847a8f21246910909e2a4e3b942bcbde32f052cba0510177821ccd7de82a59b: [Teva Pharmaceutical key executives](https://financialmodelingprep.com/stable/key-executives?symbol=TEVA). - alpha:projection-evidence:d30652de3ed1de87ba57e1a2d50ab35859624ae1cc6f78b9228b52be6b1e9c60: [Audit](https://www.sec.gov/Archives/edgar/data/818686/000119312526134756/d11977ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd) - [Public Markdown](https://registry.alpha.ac/companies/teva-pharmaceutical-industries-ltd.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/teva-pharmaceutical-industries-ltd?format=jsonld) - MCP resource: `alpha://companies/teva-pharmaceutical-industries-ltd` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-24T23:40:05.835313+00:00; recorded 2026-10-24T23:40:05.835313+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.